33rd Annual J.P. Morgan Healthcare Conference San Francisco, California January 12, 2015 Jim Skogsbergh President and Chief Executive Officer Lee B. Sacks, M.D. Executive Vice President and Chief Medical Officer Dominic J. Nakis Chief Financial Officer and Treasurer The following material and presentation contains information which is forward looking within the meaning of federal securities law. These forward-looking statements are based on the current plans and expectations of Advocate Health Care Network (“Advocate”) that, although believed to be reasonable, are subject to a number of known and unknown uncertainties and risks inherent in the operation of health care facilities, many of which are beyond Advocate’s control, that could significantly affect current plans and expectations and Advocate’s future financial position and results of operations. These forward-looking statements speak only as of the date made. Investors are cautioned not to unduly rely on such forward-looking statements. This presentation should be reviewed in conjunction with Advocate’s December 31, 2013 and September 30, 2014 continuing disclosure reports. Introduction and Advocate Overview Jim Skogsbergh President and Chief Executive Officer Advocate Health Care Hospitals (12) 4 teaching 1 children's 1 critical access 5 level 1 trauma centers Physicians 1,350 employed/affiliated 5,175 APP 6,400 Medical staff Post-acute Home health, hospice, LTAC & palliative care 33,400 associates $5.3B total revenue 17.8% market share ® Pluralistic Physician Approach Employed /Affiliated ~ 1,350 Aligned ~ 3,825 Advocate Physician Partners ~ 5,175 Advocate Medical Staff ~ 6,400 Affiliation and Merger • Silver Cross Partnership • NorthShore Merger Silver Cross - An Innovative Partnership • Joined Advocate Physician Partners • Expands Advocate’s geographic coverage • Silver Cross physicians complement Advocate Physician Partners • Provides Silver Cross access to contracts and population health expertise. • Silver Cross remains an independent entity; financial statements not consolidated into Advocate. • • • • • $300 million revenue 289 licensed beds 19,000 capitated lives 300 physicians 10 employed physicians NorthShore Merger • One board and management team • Strategic direction • Single signature managed care contracting • Consolidated financial statements and system-wide capital allocation • Combined obligated group planned NorthShore Merger Objectives & Benefits Increase competition by dramatically changing the way that managed care products are constructed and sold in the Chicago area. • Population Health Management and Clinical Integration • New Health Plan Products • Opportunities for Self-Insured Employers • Broad and Complementary Geographies Market Share - 2014 Q2 20% 17.8% 15% 9.4% 10% 9.2% 7.2% 4.9% 5% 0% Advocate Presence Northwestern/ Cadence Ascension/ Adventist NorthShore 4.5% 4.2% Rush CHE Trinity 3.8% 3.6% Edward/ Elmhurst Tenet Strong Financial Position Advocate NorthShore Rating (M/S&P/F) Aa2/AA/AA Aa2/AA/NR Net Revenue $5 B $2 B Operating Margin 5.1% 6.8% Operating Cash Flow Margin 10.8% 13.2% Net Margin 8.2% 9.2% Total Assets $10 B $3 B Days Cash on Hand 385 298 Cash to Debt 300% 373% Debt to Capitalization 23.0% 15.6% Advocate & NorthShore Alignment • Values • Outstanding quality/reputations • Highly integrated delivery systems with large employed medical groups • Strong management and governance teams • Excellent teaching and research capabilities AdvocateCare® Advancing Value Based, Coordinated Care Lee B. Sacks, M.D. Executive Vice President and Chief Medical Officer Strong Physician Engagement To drive improvement in health outcomes, care coordination and value creation through an innovative and collaborative partnership with our physicians and the Advocate System. Advocate Medical Group Dreyer Medical Group BroMenn PHO Good Samaritan PHO Sherman PHO Future PHOs Christ PHO Good Shepherd PHO South Suburban PHO Silver Cross PHO Condell PHO Illinois Masonic PHO Trinity PHO Future Medical Groups Lutheran General PHO Population Health Management (“PHM”) • PHM is the coordination or management of medical care delivery to a population to improve clinical outcomes at a lower total cost of care. • Successful PHM is a key means by which to achieve the “Triple Aim”: 1. Improving the patient experience. 2. Improving health outcomes. 3. Reducing the total cost of care. • PHM and aligned incentives are essential components for taking more financial risk. Reimbursement Model Shift 2014 0.30% 1% 12% 32% 55% Current Value Based Agreements Contract Lives Total Spend Commercial 388,000 $1.5 B Medicare Advantage 35,000 $0.3 B Advocate Employee 26,000 $0.1 B Medicare ACO 137,000 $1.7 B Medicaid ACE 62,000 $0.2 B 648,000 $3.8 B Total 14 Value Based Agreement Results • $2,000/case decrease in SNF costs • Medicare Shared Savings Program costs below benchmark • PPO trend in cost of care is 1.4% below market • Over 1 million individuals in disease and prevention registries Tactics for Success • Tactics are needed for the entire population not just the 5% poly-chronic to move the mean • Enhance focus on ambulatory care • Adjust skill mix of the care team • Benefit Plan design is essential • Behavioral health integration • Leverage “Big Data” Going Forward… • Shared Savings is a transition model • Well positioned for managed Medicaid • Medicare Advantage is opportunity for future growth • Value/Narrow Network Products for Public/Private Exchanges Financial Performance Dominic J. Nakis Chief Financial Officer and Treasurer Strong Operating Performance Dollars in Millions 400 7.8% 300 10% 6.8% 6.5% 6.1% 5.1% 200 5% 100 0 335 301 298 300 2010 2011 2012 2013 Operating Income // 195 0% 2014 YTD Q3 Operating Margin Note: Operating income and operating margin for the nine months ended September 30, 2014 are not necessarily indicative of the results that may be experienced during the year ending December 31, 2014. 25 Consistently Solid Cash Flow Dollars in Millions 600 12.7% 11.7% 11.6% 11.5% 15% 10.8% 500 400 10% 300 200 100 0 5% 545 518 532 567 2010 2011 2012 2013 Operating Cash Flow 415 // 2014 YTD Q3 0% Operating Cash Flow Margin Note: Cash generated from operations and operating cash flow margin for the nine months ended September 30, 2014 are not necessarily indicative of the results that may be experienced during the year-ending December 31, 2014. 25 Diversified Investment Portfolio 100% Dollars in Millions 550 20% 10.5% -0.2% 10.6% 7.1% 3.4% 350 90% 80% 10% 70% 15% 16% Real Assets 20% 22% Hedge Funds 25% 24% Fixed Income 10% 8% Private Equity 30% 30% Public Equity Target Actual Sept 30 60% 0% 150 40% 193 -10% 351 439 361 (34) (50) 2010 2011 Investment Income 2012 // 50% 30% 20% -20% 2013 2014 YTD Q3 Investment Yield Note: The 2014 Q3 YTD investment yield is not annualized. Both investment income and yield are net of fees. 10% 0% Expected return of 7.2%. Risk/return ratio at 0.76. 27 Debt Profile = Low, Level and Long* Tax-exempt debt is $1.5 billion, average annual debt service is generally level through 2038 at $90 million and average life is 19 years. Maximum Annual Debt Service: $90.2 million $100 $90 Debt Service (in $millions) $80 $70 $60 $50 $40 $30 $20 $10 $0 2014 2016 2018 2020 2022 2024 2026 * Debt profile as of December 18, 2014. 2028 2030 2032 2034 2036 2038 2040 2042 2044 2046 2048 2050 Well Diversified Debt Portfolio* Underlying Mix Liquidity Mix JP Morgan, $185.43mm, 12% Synthetic Fixed, $321.3mm, 21% Wells Fargo, $49.2mm, 3% Fixed Rate $839.4mm, 55% Northern Trust, $86.6mm, 6% Intermediate, $181.0mm, 12% Self-Liquidity, $355.5mm, 24% Variable Rate, $170.0mm, 11% Product Mix Windows VRDBs, $70.0mm, 5% Weekly VRDBs, $321.3mm, 21% Multi-Annual Tender, $120.3mm, 8% Direct Purchase, $100.0mm, 7% Annual Tender, $65.1mm, 4% * Debt portfolio as of December 18, 2014. Fixed Rate, $839.4mm, 55% None, $839.4mm, 55% Strong Coverage and Capitalization 23.5% 26.1% 24.5% 24.2% 23.0% 12.0 40% 35% 10.0 30% Times 8.0 25% 6.0 20% 15% 4.0 10% 2.0 0.0 10.1 8.7 11.1 9.5 2010 2011 2012 2013 Debt Service Coverage Ratio (times) // 10.3 5% 0% 2014 Q3 Debt as % of Unrestricted Capitalization Note: 2014 Q3 YTD is a rolling twelve month period. 31 Strong Cash to Debt Ratio 310 Percent 300 290 280 270 260 250 240 281 263 285 282 2010 2011 2012 2013 // 300 2014 Q3 32 Dollars in Millions 6,000 5,000 304 289 351 386 385 4,763 4,000 3,000 2,000 1,000 0 2,920 3,211 3,842 4,518 2010 2011 2012 2013 Dollars // 450 400 350 300 250 200 150 100 50 0 Days on Hand Substantial Liquidity Position 2014 Q3 Days Cash and Investments on Hand 34 Well Funded Pension Plans Dollars in Millions 800 92% 86% 750 99% 100% 100% 90% 95% 700 80% 650 707 600 550 673 835 762 654 768 840 889 838 882 // 500 2010 2011 Assets 2012 PBO 2013 70% 60% 50% 2014 Q3 Percent Funded 33 Large Capital Commitments Past 3 Years 900 250% 208% 750 200% Dollars in Millions 146% 182% 150% 600 150% 450 108% 100% 300 50% 150 0 310 179 640 2010 New Commitments 251 2011 853 281 2012 Cash Spending 487 386 2013 // 353 446 0% Nov. 2014 Capital Spend Ratio 35 Summary National leader in: – Health outcomes and safety – Value based health care Metro Chicago market share leader and brand strength Growth through selective acquisitions and ability to integrate new hospitals and physicians Pluralistic approach to physician relationships coupled with a large and growing employed medical group Balance sheet strength and solid operating performance All of above reflected in our bond ratings of Aa2/AA/AA (M/S&P/F), with stable (M/F) and positive (S&P) outlooks 42 Disclosure Audited financial statements, quarterly reports along with management’s discussion and analysis and the annual continuing disclosure report are available on the Advocate, Digital Assurance Certification, LLC and Municipal Securities Rulemaking Board websites. To view online visit: www.advocatehealth.com/body_full.cfm?id=2839 www.dacbond.com www.emma.msrb.org 31 Thank you!